ArticlePloS one2013

Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.

Eva Juengel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.